findmyKOL

Josiah Rich, MD

Basic profile

Brown University

ORCID↗NPI↗
✓ Full record
RegionProvidence, RI · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL type: NationalLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH funding1995–2026Why? →

Josiah Rich is an Infectious Disease physician affiliated with Brown University. OpenAlex indexes 467 publications with 14,300 citations (h-index 63); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
467publications

Distinct works indexed by OpenAlex, matched via ORCID.

14,300citations

Total citations across indexed works.

63h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
14NIH grants · 1995–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1125 N Main St
Providence, RI 029045739

Telephone

401-793-2928

Provider last certified this registry record 25 Mar 2026.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    40.7%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor17.8%
    Dovato81%Tivicay19%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.8%
    Triumeq100%
    Part D<11 patients

    + 3 more classes in this area

  • Cardiovascular

    27.7%
    Statin11.2%
    Atorvastatin Calcium62%Rosuvastatin Calcium39%
    Part D<11 patients
    Calcium channel blocker7.5%
    Amlodipine Besylate100%
    Part D<11 patients

    + 3 more classes in this area

  • Nervous system

    13.5%
    Opioid Agonist4.9%
    Oxycodone Hcl53%Morphine Sulfate Er47%
    Part D<11 patients
    Partial Opioid Agonist3.2%
    Buprenorphine-Naloxone100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

14 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”